AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,092,600 | -98.8% | 90,000 | +8749.6% | 0.37% | -62.7% |
Q2 2022 | $94,600,000 | +8547.2% | 1,017 | -98.9% | 0.99% | +299.6% |
Q1 2022 | $1,094,000 | 0.0% | 94,600 | 0.0% | 0.25% | +1.2% |
Q4 2021 | $1,094,000 | +21.0% | 94,600 | 0.0% | 0.24% | +11.9% |
Q3 2021 | $904,000 | -0.9% | 94,600 | 0.0% | 0.22% | -9.5% |
Q2 2021 | $912,000 | -2.5% | 94,600 | 0.0% | 0.24% | -2.4% |
Q1 2021 | $935,000 | -57.2% | 94,600 | 0.0% | 0.25% | -58.6% |
Q4 2020 | $2,185,000 | +63.5% | 94,600 | 0.0% | 0.60% | +38.5% |
Q3 2020 | $1,336,000 | -9.1% | 94,600 | 0.0% | 0.43% | -11.9% |
Q2 2020 | $1,470,000 | +68.4% | 94,600 | 0.0% | 0.49% | +22.9% |
Q1 2020 | $873,000 | -5.1% | 94,600 | 0.0% | 0.40% | +20.2% |
Q4 2019 | $920,000 | +95.7% | 94,600 | +61.4% | 0.33% | +52.5% |
Q3 2019 | $470,000 | -35.6% | 58,600 | 0.0% | 0.22% | -19.9% |
Q2 2019 | $730,000 | -8.3% | 58,600 | 0.0% | 0.27% | -7.8% |
Q1 2019 | $796,000 | +80.9% | 58,600 | 0.0% | 0.29% | +7.7% |
Q4 2018 | $440,000 | -19.0% | 58,600 | 0.0% | 0.27% | +5.8% |
Q3 2018 | $543,000 | -40.7% | 58,600 | 0.0% | 0.26% | -26.5% |
Q2 2018 | $915,000 | +3.9% | 58,600 | 0.0% | 0.35% | +2.0% |
Q1 2018 | $881,000 | +4.5% | 58,600 | 0.0% | 0.34% | +15.8% |
Q4 2017 | $843,000 | -4.5% | 58,600 | 0.0% | 0.30% | -13.7% |
Q3 2017 | $883,000 | +223.4% | 58,600 | +6.5% | 0.34% | +179.7% |
Q4 2016 | $273,000 | – | 55,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |